Is POLE p.His511= (c.1533C>T) pathogenic?

POLE p.His511= (c.1533C>T) is classified Likely benign in POLE (ClinVar, Multiple submitters, 5 submitters; last evaluated 2025-11-12). Ultra-rare (popmax 0.0165%, sas); Associated with hereditary neoplastic syndrome.

What condition is associated with POLE p.His511= (c.1533C>T)?

POLE p.His511= (c.1533C>T) is associated with hereditary neoplastic syndrome (ClinVar).

How common is POLE p.His511= (c.1533C>T) in the general population?

POLE p.His511= (c.1533C>T) is ultra-rare (popmax 0.0165%, sas) (gnomAD).

POLE p.His511=

c.1533C>T · rs545378475 · VCV473466

Likely benign Multiple submitters

Classification

Likely benign

ClinVar

Review

Multiple submitters ★★☆☆

ClinVar · 5 submitters

gnomAD v4.1

Rare

ultra-rare (popmax 0.0165%, sas)

Conditions

hereditary neoplastic syndrome

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Splicing
SpliceAI	—	not assessed · no allele here is in the release
Constraint at this position
Conservation	phyloP -4	GERP -3.7
Overall
CADD	1.327	PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes

Grpmax group 0.0165% South Asian · 15/91,086 alleles

Filtering AF 0.0101% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.00811%

Overall 0.00248% 40/1,614,176 alleles · ultra-rare exomes 39/1,461,840 · genomes 1/152,336 · joint denominator

Ancestry group	Frequency	1 in
South Asiangrpmax	0.0165%	6,072
East Asian	0.00446%	22,441
Admixed American	0.00333%	30,012
European (non-Finnish)	0.00178%	56,192

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene: POLE
Protein: p.His511=
Coding: c.1533C>T
MANE Select: NM_006231
dbSNP: rs545378475
Type: single nucleotide variant
Location: chr12:132672780 (GRCh38)
Gene constraint: LOEUF 0.75 · pLI <0.01 · ClinGen HI 1/3 (gnomAD)
Structure: AlphaFold pLDDT 80.32 · 18 PDB
Residue 511: an α-helix

Full POLE gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

hereditary neoplastic syndrome — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

Similar variants

POLE p.His511Gln Uncertain significance ★★ ⚠ same residue
POLE p.His511Tyr Uncertain significance ★ ⚠ same residue
POLE c.1686+32C>G Pathogenic/Likely pathogenic ★★ same condition
POLE p.Leu424Val Pathogenic ★★ same condition
POLE c.1020+5G>A Uncertain significance ★★ same condition
POLE c.1106+3G>C Uncertain significance ★★ same condition
POLE c.1106+4A>G Uncertain significance ★★ same condition
POLE c.1226+3A>G Uncertain significance ★★ same condition

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/pole-p-his511 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown